Drug
Adt Docetaxel Enzalutamide
Adt Docetaxel Enzalutamide: highest development phase Phase 2, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ADT+Docetaxel+Enzalutamide NCT03246347 | Phase 2 | Prostate Cancer |
Latest
No recent events.
Follow Adt Docetaxel Enzalutamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.